Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderly patients. Therefore, a systematic review was don...

Full description

Bibliographic Details
Main Authors: Mohammed Ahmed Akkaif, Abubakar Sha’aban, Nur Aizati Athirah Daud, Ismaeel Yunusa, Mei Li Ng, Muhamad Ali Sk Abdul Kader, Dzul Azri Mohamed Noor, Baharudin Ibrahim
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
ticagrelor
clopidogrel
systematic review
meta-analysis
randomized controlled trials
Online Access:https://www.mdpi.com/2308-3425/8/10/123

Internet

https://www.mdpi.com/2308-3425/8/10/123

Similar Items